← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2015Last known activity
Dec 16, 2019
Acquired by Strongbridge Biopharma → Xeris Pharmaceuticals on Sep 8, 2015
Timeline
2010s
- Jun 1, 2015
Cortendo AB— Founded
- Sep 8, 2015
Strongbridge Biopharma— Acquired By
2020s
- Jul 24, 2021
Drugs by trial phase (2 distinct, 6 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT04212000Lead sponsorPhase 1Dec 16, 2019
- NCT04212000Study directorPhase 1Dec 16, 2019
- NCT03880825Lead sponsorPhase 1Mar 28, 2019
- NCT03880825Study directorPhase 1Mar 28, 2019
- NCT03768388Lead sponsorPhase 1Nov 30, 2018
- NCT03768388Study directorPhase 1Nov 30, 2018
- NCT03621280Lead sponsorPhase 3Aug 20, 2018
- NCT03621280Study directorPhase 3Aug 20, 2018
- NCT03277690Study directorPhase 3Sep 26, 2017
- NCT03277690Lead sponsorPhase 3Sep 26, 2017
- NCT01838551Study directorPhase 3Aug 1, 2014
- NCT01838551Lead sponsorPhase 3Aug 1, 2014
Details
- Founded
- Partille, SE Jun 1, 2015
- Last known activity
- Dec 16, 2019